These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17936515)

  • 41. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption.
    Lee JY; Lee HE; Kang SR; Choi HY; Ryu JH; Yune TY
    Neuropharmacology; 2014 Apr; 79():161-71. PubMed ID: 24316161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.
    Wang YF; Tsirka SE; Strickland S; Stieg PE; Soriano SG; Lipton SA
    Nat Med; 1998 Feb; 4(2):228-31. PubMed ID: 9461198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.
    Ranasinghe HS; Williams CE; Christophidis LJ; Mitchell MD; Fraser M; Scheepens A
    Neuroscience; 2009 Jan; 158(2):732-44. PubMed ID: 18809469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.
    Asahi M; Wang X; Mori T; Sumii T; Jung JC; Moskowitz MA; Fini ME; Lo EH
    J Neurosci; 2001 Oct; 21(19):7724-32. PubMed ID: 11567062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein.
    Sakurai-Yamashita Y; Sakaguchi S; Yoshikawa D; Okimura N; Masuda Y; Katamine S; Niwa M
    Neuroscience; 2005; 136(1):281-7. PubMed ID: 16198494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marked increases in hippocampal neuron indoleamine 2, 3-dioxygenase via IFN-gamma-independent pathway following transient global ischemia in mouse.
    Hoshi M; Saito K; Murakami Y; Taguchi A; Fujigaki H; Tanaka R; Takemura M; Ito H; Hara A; Seishima M
    Neurosci Res; 2009 Mar; 63(3):194-8. PubMed ID: 19121343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia.
    Cui M; Wang L; Liang X; Ma X; Liu Y; Yang M; Liu K; Wei X; Zhou Z; Chen YH; Sun W
    Neurobiol Dis; 2010 Aug; 39(2):138-47. PubMed ID: 20359534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
    Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
    J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats.
    Lei S; Zhang P; Li W; Gao M; He X; Zheng J; Li X; Wang X; Wang N; Zhang J; Qi C; Lu H; Chen X; Liu Y
    ASN Neuro; 2014; 6(6):. PubMed ID: 25388889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress.
    Yabuki Y; Fukunaga K
    Neuroscience; 2013 Oct; 250():394-407. PubMed ID: 23872392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.
    Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H
    Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD47 gene knockout protects against transient focal cerebral ischemia in mice.
    Jin G; Tsuji K; Xing C; Yang YG; Wang X; Lo EH
    Exp Neurol; 2009 May; 217(1):165-70. PubMed ID: 19233173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phospholipase D1-promoted release of tissue plasminogen activator facilitates neurite outgrowth.
    Zhang Y; Kanaho Y; Frohman MA; Tsirka SE
    J Neurosci; 2005 Feb; 25(7):1797-805. PubMed ID: 15716416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.
    Flavin MP; Zhao G
    J Neurosci Res; 2001 Mar; 63(5):388-94. PubMed ID: 11223913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
    Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
    Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms.
    Henrich-Noack P; Prehn JH; Krieglstein J
    Stroke; 1996 Sep; 27(9):1609-14; discussion 1615. PubMed ID: 8784137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice.
    Kurata K; Maruyama S; Kato S; Sato W; Yamamoto J; Ozaki T; Nitta A; Nabeshima T; Morita Y; Mizuno M; Ito Y; Yuzawa Y; Matsuo S
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1510-7. PubMed ID: 19934446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.